GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Stenocare AS (OCSE:STENO) » Definitions » Cash Flow for Lease Financing

Stenocare AS (OCSE:STENO) Cash Flow for Lease Financing : kr-0.29 Mil (TTM As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is Stenocare AS Cash Flow for Lease Financing?

Stenocare AS's Cash Flow for Lease Financing for the three months ended in Mar. 2025 was kr-0.05 Mil. Stenocare AS's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Mar. 2025 was kr-0.29 Mil.

Compared with last quarter (kr-0.01 Mil in Dec. 2024 ), Stenocare AS's Cash Flow for Lease Financing remained the same in Mar. 2025 (kr-0.05 Mil).

Stenocare AS Cash Flow for Lease Financing Historical Data

The historical data trend for Stenocare AS's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stenocare AS Cash Flow for Lease Financing Chart

Stenocare AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Flow for Lease Financing
Get a 7-Day Free Trial - 1.24 0.44 -0.31 -0.44

Stenocare AS Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cash Flow for Lease Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.20 -0.12 -0.11 -0.01 -0.05

Stenocare AS Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.


Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.29 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stenocare AS Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of Stenocare AS's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Stenocare AS Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Stenocare AS (OCSE:STENO) » Definitions » Cash Flow for Lease Financing
Comparable Companies
ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA SHSE:688506 BOM:500087 SZSE:000538 TSE:4507 UTHR NSE:TORNTPHARM BOM:500124 NBIX BOM:543904 BOM:532321
Traded in Other Exchanges
N/A
Address
Nyholmsvej 4, Randers NØ, DNK, 8930
Website
https://www.stenocare.com
Stenocare AS is a Danish company engaged in the cultivation and production of medical cannabis products through pharmacies and hospitals. The Company's business operations include the distribution and sales of imported products to several markets which also includes local cultivation and production of its medical cannabis products. Stenocare is well positioned to become a market leader in Denmark and a vendor in Europe. The Company is a supplier of medical cannabis oil for patients in Denmerk, Sweden, UK, Australia and Norway. It has an indoor production facility for the cultivation and production of medical cannabis at Randers, Denmark.

Stenocare AS Headlines

No Headlines